Stocks to sell and stocks to buy diverge in a correction... 'Replacement strategy' more important than stop-loss

Stocks to sell and stocks to buy diverge in a correction... 'Replacement strategy' more important than stop-loss | Myeong Min-jun, Kang A-rang, Lee Ji-hwan [Stock Beginner Rescue Team]
Watch on YouTube ↗  |  June 09, 2026 at 14:00  |  49:48  |  3PRO TV (삼프로TV)
Speakers
Lee Ji-hwan — CEO, Aurora Investment Advisory

Summary

Lee Ji-hwan, CEO of Aurora Investment Advisory, explains how to distinguish a short-term correction from a structural downtrend and how to position accordingly. He dissects the four triggers behind the recent semiconductor plunge and argues they are overblown, leaving AI-driven memory leaders like Samsung Electronics and SK Hynix as strong buys on the dip. He advises exiting biotech as the rate-cut cycle ends, avoiding KOSDAQ until rate-hike talk materializes, and using inverse ETFs to hedge during sharp sell-offs. The core message is that retail investors should replace losing non-leaders with market leaders during corrections to stay in the AI bull trend.

  • The semiconductor sell-off was driven by exaggerated rate-hike fears, misunderstood memory capacity changes, non-representative Broadcom guidance, and short-term profit-taking.
  • All four fears lack fundamental weight; AI demand is intact and memory stocks remain the dominant leaders.
  • Investors should buy Samsung Electronics and SK Hynix on weakness because leaders tend to fall more in corrections but recover much more strongly.
  • Biotech/pharma stocks, having surged during the rate-cut cycle, are near a top as rate cuts end; exit biotech now.
  • KOSDAQ typically rallies when rate hikes actually begin; avoid it until that phase starts.
  • During sharp market-wide drops, hedge quality long positions with KOSPI inverse ETFs instead of selling the stocks.
  • Non-leaders such as HYBE should be sold and rotated into AI-beneficiaries to keep capital working effectively.
  • Psychological biases like loss aversion cause investors to hold losers; a replacement mindset helps overcome this.
Ideas
Lee Ji-hwan CEO, Aurora Investment Advisory 5:22
Buy Samsung, SK Hynix on dip
The recent sharp sell-off in memory semiconductors (Samsung Electronics, SK Hynix) was caused by four temporary factors: an overblown rate-hike scare, a misinterpreted reduction in memory capacity in next-gen AI chips (supply constraints make higher volume impossible anyway), Broadcom's weak AI guidance that does not reflect the overall AI industry, and profit-taking after a 2-3x short-term rally. The AI demand story remains intact and there is no alternative to AI, so the memory sector remains the market leader. Historical pattern shows that leaders fall harder during corrections due to profit-taking but rebound more strongly afterward. This dip is a buying opportunity in the leaders.
Lee Ji-hwan CEO, Aurora Investment Advisory 21:54
Hedge with KOSPI inverse during corrections
During sharp market-wide declines when one's own quality stocks are being dragged down without fundamental reason, instead of selling the stocks, investors can buy inverse ETFs to hedge the portfolio. This allows keeping the long positions while protecting against short-term downside.
Lee Ji-hwan CEO, Aurora Investment Advisory 33:08
Avoid HYBE, swap into leaders
HYBE is not a market leader and does not benefit from the AI momentum that is driving the current bull market. During a correction, investors should sell such non-leaders and rotate into leading AI-driven stocks like Samsung Electronics and SK Hynix to increase recovery potential.
Lee Ji-hwan CEO, Aurora Investment Advisory 41:39
Avoid biotech as rate cuts end
Biotech/pharma stocks have rallied many-fold over the past few years as rates fell, because the sector is highly leveraged to lower interest rates. Now that the rate-cut cycle is effectively over and rate-hike talk is emerging, the biotech rally is at its peak and the sector will likely fade. The speaker advises to exit biotech positions now.
Lee Ji-hwan CEO, Aurora Investment Advisory 42:43
Avoid KOSDAQ until rate hike begins
KOSDAQ typically makes its big move when the rate-hike cycle actually begins, not during the current late-cycle rate-cut phase. Until then, KOSDAQ is not attractive. Investors should wait for the rate-hike initiation to buy KOSDAQ and avoid it for now.
Up Next

This 3PRO TV (삼프로TV) video, published June 09, 2026, features Lee Ji-hwan discussing 005930.KS, 000660.KS, KOSPI Inverse ETF, 352820.KS, Korean Biotech/Pharma Sector, KOSDAQ Index. 5 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Ji-hwan  · Tickers: 005930.KS, 000660.KS, KOSPI Inverse ETF, 352820.KS, Korean Biotech/Pharma Sector, KOSDAQ Index